BETAMETHASONE DIPROPIONATE

BETAMETHASONE DIPROPIONATE was reported 6696 times

BETAMETHASONE DIPROPIONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 45 0.3462
1 SLEEP DISORDER THERAPY 54 0.2727
2 VAGINAL FLATULENCE 81 0.2673
3 PULMONARY VASCULITIS 119 0.2212
4 CAPILLARITIS 51 0.1848
5 CONGENITAL HIATUS HERNIA 41 0.1798
6 ANALGESIC THERAPY 57 0.1776
7 MALIGNANT MELANOMA STAGE 0 36 0.1722
8 APPENDICOLITH 66 0.1705
9 PROTOTHECOSIS 16 0.1702
10 TOTAL LUNG CAPACITY ABNORMAL 66 0.1697
11 DRUG THERAPY 56 0.1652
12 ANTICOAGULANT THERAPY 45 0.1585
13 SPIROMETRY ABNORMAL 85 0.1421
14 MITE ALLERGY 89 0.1359
15 TOPICAL STEROID WITHDRAWAL REACTION 52 0.1337
16 MYCOTIC ALLERGY 88 0.1029
17 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 67 0.0914
18 DUST ALLERGY 88 0.0897
19 BACTEROIDES INFECTION 20 0.0766
20 NEURITIS 118 0.0764
21 NAIL BED INFLAMMATION 24 0.0752
22 GASTROENTERITIS ASTROVIRAL 6 0.0750
23 CONJUNCTIVITIS ALLERGIC 93 0.0628
24 HYPOCHOLESTEROLAEMIA 22 0.0623
25 BACTERIAL VULVOVAGINITIS 16 0.0554
26 RESPIRATORY SYMPTOM 150 0.0527
27 FEMALE GENITAL TRACT FISTULA 89 0.0521
28 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 104 0.0510
29 OVERLAP SYNDROME 35 0.0500
30 MACULAR DEGENERATION 533 0.0446
31 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 41 0.0442
32 SOFT TISSUE INJURY 32 0.0423
33 DERMATOPHYTOSIS OF NAIL 5 0.0420
34 NASAL MUCOSAL DISORDER 24 0.0412
35 POST-TRAUMATIC NECK SYNDROME 32 0.0396
36 HYPERPHOSPHATAEMIA 72 0.0335
37 RADICULOPATHY 88 0.0334
38 STREPTOCOCCAL SEPSIS 38 0.0320
39 NORMOCHROMIC NORMOCYTIC ANAEMIA 93 0.0309
40 CHRONIC SINUSITIS 112 0.0298
41 PROCTITIS 81 0.0289
42 ANHIDROSIS 11 0.0270
43 STERNAL FRACTURE 32 0.0259
44 ECZEMA HERPETICUM 12 0.0259
45 LUPUS VULGARIS 32 0.0254
46 BACILLUS INFECTION 16 0.0253
47 CENTRAL OBESITY 18 0.0244
48 FORCED EXPIRATORY VOLUME DECREASED 69 0.0243
49 MULTIPLE DRUG THERAPY 17 0.0225
50 BLOOD PHOSPHORUS INCREASED 61 0.0223
51 PSEUDOMONAL SEPSIS 39 0.0222
52 PULMONARY ALVEOLAR HAEMORRHAGE 123 0.0219
53 NEUROLOGICAL SYMPTOM 118 0.0206
54 RETINITIS 34 0.0197
55 WOUND INFECTION PSEUDOMONAS 6 0.0192
56 MIXED ANXIETY AND DEPRESSIVE DISORDER 7 0.0189
57 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 6 0.0167
58 C-REACTIVE PROTEIN 15 0.0162
59 ARTERIOSCLEROSIS CORONARY ARTERY 107 0.0161
60 LIBIDO INCREASED 32 0.0158
61 GUTTATE PSORIASIS 12 0.0146
62 LICHENIFICATION 6 0.0146
63 ECZEMA NUMMULAR 7 0.0143
64 FULL BLOOD COUNT ABNORMAL 143 0.0135
65 PERSONALITY DISORDER 35 0.0133
66 SERONEGATIVE ARTHRITIS 15 0.0131
67 PLEURITIC PAIN 36 0.0130
68 STEROID WITHDRAWAL SYNDROME 13 0.0127
69 HOSTILITY 32 0.0126
70 STEROID DEPENDENCE 11 0.0125
71 TOTAL LUNG CAPACITY DECREASED 19 0.0119
72 INFLAMMATORY PAIN 8 0.0118
73 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 58 0.0114
74 DISLOCATION OF VERTEBRA 26 0.0114
75 NAIL PSORIASIS 7 0.0113
76 OBSTRUCTIVE AIRWAYS DISORDER 126 0.0113
77 SCROTAL PAIN 6 0.0111
78 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 185 0.0109
79 ARTERIOSCLEROSIS 101 0.0107
80 PNEUMOCOCCAL SEPSIS 7 0.0107
81 VENTRICULAR DYSFUNCTION 27 0.0104
82 BLOOD URIC ACID INCREASED 60 0.0104
83 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 177 0.0103
84 MYASTHENIA GRAVIS 83 0.0103
85 VASCULITIS 119 0.0102
86 CUSHING'S SYNDROME 7 0.0101
87 IRON DEFICIENCY 45 0.0100
88 AORTIC STENOSIS 34 0.0098
89 FEMALE STERILISATION 5 0.0097
90 HYPOPHOSPHATAEMIA 71 0.0096
91 VASCULAR DEVICE INFECTION 41 0.0090
92 PORPHYRIA ACUTE 12 0.0084
93 BREATH SOUNDS ABNORMAL 41 0.0083
94 SKIN ATROPHY 47 0.0082
95 SKIN WEEPING 29 0.0081
96 VAGINAL DISCHARGE 82 0.0081
97 DRUG ERUPTION 142 0.0080
98 LUNG OPACITY 21 0.0080
99 TROPONIN INCREASED 60 0.0079
100 HYPERCHOLESTEROLAEMIA 76 0.0079
101 APPENDICITIS 72 0.0077
102 ORAL CANDIDIASIS 100 0.0076
103 PERIPHERAL VENOUS DISEASE 31 0.0076
104 PULMONARY FIBROSIS 145 0.0076
105 BENIGN PROSTATIC HYPERPLASIA 39 0.0075
106 ENDOMETRITIS 5 0.0075
107 CUSHINGOID 24 0.0075
108 PARAESTHESIA ORAL 107 0.0074
109 FACET JOINT SYNDROME 24 0.0074
110 NODULE 96 0.0073
111 PRURITUS GENITAL 17 0.0072
112 SEBORRHOEIC KERATOSIS 10 0.0069
113 SYSTOLIC DYSFUNCTION 7 0.0066
114 LEFT VENTRICULAR FAILURE 22 0.0064
115 SYSTEMIC CANDIDA 16 0.0064
116 VARICOSE VEIN 32 0.0062
117 DACTYLITIS 6 0.0061
118 ERYTHRODERMIC PSORIASIS 5 0.0061
119 VENTRICULAR FIBRILLATION 67 0.0060
120 ESSENTIAL HYPERTENSION 11 0.0060
121 PARONYCHIA 26 0.0059
122 STAPHYLOCOCCAL BACTERAEMIA 25 0.0057
123 BLOOD CALCIUM INCREASED 50 0.0057
124 SWOLLEN JOINT COUNT INCREASED 18 0.0056
125 METASTASES TO LYMPH NODES 38 0.0056
126 ANAEMIA MACROCYTIC 12 0.0056
127 BREAST CANCER STAGE III 36 0.0056
128 HYPERLIPIDAEMIA 66 0.0055
129 DEEP VEIN THROMBOSIS POSTOPERATIVE 11 0.0055
130 SKIN PLAQUE 46 0.0054
131 BLEPHAROSPASM 34 0.0054
132 IMPETIGO 8 0.0054
133 INFUSION SITE REACTION 16 0.0054
134 SKIN FISSURES 104 0.0053
135 PEMPHIGOID 40 0.0053
136 RHEUMATIC FEVER 23 0.0052
137 CONCUSSION 38 0.0049
138 DERMATITIS EXFOLIATIVE GENERALISED 17 0.0049
139 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 10 0.0048
140 HAEMOPTYSIS 134 0.0048
141 CARDIOGENIC SHOCK 68 0.0047
142 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 330 0.0046
143 SERUM FERRITIN DECREASED 8 0.0046
144 BACTERIAL INFECTION 86 0.0046
145 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 33 0.0046
146 FREQUENT BOWEL MOVEMENTS 124 0.0046
147 POLYDIPSIA 18 0.0045
148 BONE EROSION 16 0.0045
149 EXERCISE TOLERANCE DECREASED 26 0.0045
150 FOLLICULITIS 47 0.0045
151 PSORIATIC ARTHROPATHY 175 0.0043
152 HYPOTHYROIDISM 137 0.0043
153 DRUG TOLERANCE DECREASED 12 0.0043
154 ULCER 67 0.0042
155 ASPIRATION 46 0.0042
156 BLOOD PRESSURE INADEQUATELY CONTROLLED 25 0.0042
157 PROCEDURAL PAIN 115 0.0041
158 LUNG DISORDER 200 0.0041
159 ONYCHOCLASIS 28 0.0041
160 PSORIASIS 515 0.0039
161 SPONDYLITIS 14 0.0038
162 HEPATIC FUNCTION ABNORMAL 143 0.0038
163 LIVE BIRTH 32 0.0038
164 NEURALGIA 93 0.0038
165 SKIN EROSION 12 0.0037
166 END STAGE RENAL DISEASE 67 0.0037
167 SEBORRHOEIC DERMATITIS 6 0.0036
168 GOUT 65 0.0036
169 BREAST CANCER STAGE II 30 0.0036
170 ADRENOCORTICAL INSUFFICIENCY ACUTE 7 0.0036
171 EXOSTOSIS 32 0.0035
172 SPONDYLOLISTHESIS 6 0.0035
173 MULTIPLE ORGAN DYSFUNCTION SYNDROME 97 0.0034
174 POLYCYTHAEMIA 7 0.0034
175 CANDIDA INFECTION 57 0.0034
176 HYPOXIA 118 0.0033
177 SKIN DISCOMFORT 9 0.0033
178 MICTURITION URGENCY 38 0.0033
179 GRIP STRENGTH DECREASED 29 0.0033
180 BLOOD TEST ABNORMAL 46 0.0033
181 INCORRECT DOSAGE ADMINISTERED 16 0.0033
182 HAEMATOLOGICAL INFECTION 8 0.0033
183 IMMUNE-MEDIATED ADVERSE REACTION 5 0.0033
184 BACK INJURY 35 0.0032
185 HELICOBACTER INFECTION 33 0.0032
186 PUSTULAR PSORIASIS 11 0.0032
187 ESCHERICHIA INFECTION 26 0.0032
188 BURSITIS 38 0.0031
189 JOINT RANGE OF MOTION DECREASED 42 0.0031
190 ONYCHOMADESIS 13 0.0031
191 DERMATITIS ATOPIC 160 0.0030
192 RED BLOOD CELL SEDIMENTATION RATE INCREASED 33 0.0030
193 LOSS OF EMPLOYMENT 9 0.0030
194 DERMATITIS PSORIASIFORM 6 0.0029
195 ULCERATIVE KERATITIS 8 0.0029
196 ACUTE SINUSITIS 5 0.0029
197 ECZEMA 151 0.0029
198 AUTOIMMUNE DISORDER 28 0.0029
199 NAIL DISORDER 25 0.0029
200 WHEEZING 169 0.0028
201 ACUTE PSYCHOSIS 7 0.0028
202 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 135 0.0028
203 INDURATION 5 0.0028
204 METASTASES TO CENTRAL NERVOUS SYSTEM 36 0.0028
205 FURUNCLE 22 0.0028
206 MUSCLE INJURY 23 0.0028
207 BRAIN OEDEMA 35 0.0028
208 COLITIS 105 0.0028
209 LIP DRY 25 0.0027
210 STOMATITIS 166 0.0027
211 GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0027
212 PRODUCT PHYSICAL CONSISTENCY ISSUE 15 0.0027
213 COLITIS ULCERATIVE 120 0.0027
214 SLEEP DISORDER 189 0.0027
215 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 7 0.0026
216 LICHEN PLANUS 6 0.0026
217 SKIN HYPERPIGMENTATION 22 0.0026
218 PAPULE 18 0.0026
219 POOR QUALITY SLEEP 55 0.0026
220 ASCITES 74 0.0025
221 SKIN LESION 69 0.0025
222 JOINT INJURY 53 0.0025
223 ADRENAL INSUFFICIENCY 30 0.0025
224 RECTAL HAEMORRHAGE 106 0.0025
225 GLOSSODYNIA 55 0.0025
226 HAND DEFORMITY 32 0.0024
227 WOUND 68 0.0024
228 DIABETIC NEUROPATHY 12 0.0024
229 TENDON INJURY 9 0.0024
230 SKIN SWELLING 21 0.0024
231 THERAPEUTIC PRODUCT EFFECT DELAYED 11 0.0024
232 LUMBAR SPINAL STENOSIS 7 0.0024
233 SWELLING OF EYELID 15 0.0024
234 PLANTAR FASCIITIS 8 0.0024
235 C-REACTIVE PROTEIN INCREASED 86 0.0024
236 SKIN HAEMORRHAGE 35 0.0024
237 MIDDLE INSOMNIA 44 0.0024
238 SKIN EXFOLIATION 198 0.0023
239 IRRITABLE BOWEL SYNDROME 50 0.0023
240 PERICARDITIS 39 0.0023
241 ACTINIC KERATOSIS 6 0.0023
242 INFUSION RELATED REACTION 153 0.0023
243 THROMBOSIS 184 0.0023
244 TASTE DISORDER 46 0.0023
245 HAEMORRHAGIC DIATHESIS 8 0.0022
246 PRODUCTIVE COUGH 107 0.0022
247 PYODERMA GANGRENOSUM 8 0.0022
248 SKIN WRINKLING 6 0.0022
249 DYSLIPIDAEMIA 11 0.0022
250 MACULE 6 0.0022
251 ASTHMA 242 0.0021
252 BLOOD CHOLESTEROL INCREASED 97 0.0021
253 OBESITY 33 0.0021
254 RASH VESICULAR 10 0.0021
255 FINGER DEFORMITY 10 0.0021
256 SYNOVITIS 37 0.0020
257 RIB FRACTURE 42 0.0020
258 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
259 DUODENAL ULCER PERFORATION 15 0.0020
260 DERMATITIS CONTACT 23 0.0020
261 HAEMATOCHEZIA 111 0.0020
262 SECRETION DISCHARGE 25 0.0020
263 UPPER RESPIRATORY TRACT INFECTION 92 0.0020
264 PULMONARY EMBOLISM 186 0.0020
265 INCREASED BRONCHIAL SECRETION 5 0.0020
266 PULMONARY MASS 29 0.0019
267 LOCALISED OEDEMA 9 0.0019
268 ROSACEA 9 0.0019
269 PURPURA 17 0.0019
270 HYPONATRAEMIA 108 0.0019
271 APPLICATION SITE PAIN 42 0.0019
272 RHEUMATOID FACTOR POSITIVE 11 0.0019
273 POLYARTHRITIS 10 0.0019
274 NON-CARDIAC CHEST PAIN 6 0.0019
275 FREEZING PHENOMENON 7 0.0019
276 NEURODERMATITIS 7 0.0019
277 DYSPEPSIA 184 0.0019
278 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
279 DIABETES MELLITUS INADEQUATE CONTROL 33 0.0019
280 BODY TEMPERATURE INCREASED 38 0.0019
281 CONTRAINDICATED PRODUCT ADMINISTERED 56 0.0018
282 ERYTHEMA MULTIFORME 17 0.0018
283 LIVER FUNCTION TEST INCREASED 39 0.0018
284 OTITIS MEDIA 6 0.0018
285 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0018
286 SKIN INJURY 6 0.0018
287 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 94 0.0018
288 TRANSAMINASES INCREASED 40 0.0018
289 EPISTAXIS 133 0.0018
290 ULCER HAEMORRHAGE 12 0.0018
291 SCIATICA 28 0.0018
292 VITAMIN B12 DEFICIENCY 7 0.0017
293 RALES 10 0.0017
294 CORONARY ARTERY DISEASE 52 0.0017
295 LOWER RESPIRATORY TRACT INFECTION 78 0.0017
296 FOOT DEFORMITY 19 0.0017
297 IMPAIRED HEALING 56 0.0017
298 GAIT INABILITY 57 0.0017
299 CONTUSION 164 0.0017
300 HEPATIC CIRRHOSIS 32 0.0017
301 GROWTH RETARDATION 5 0.0017
302 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 11 0.0017
303 SKIN INFECTION 19 0.0017
304 GLOSSITIS 6 0.0017
305 PAIN OF SKIN 45 0.0017
306 CELLULITIS 84 0.0017
307 SQUAMOUS CELL CARCINOMA OF SKIN 10 0.0017
308 MUSCLE TWITCHING 38 0.0016
309 BLISTER 92 0.0016
310 DIASTOLIC DYSFUNCTION 5 0.0016
311 SKIN DISORDER 54 0.0016
312 SCRATCH 17 0.0016
313 THERAPY NON-RESPONDER 72 0.0016
314 BACTERAEMIA 19 0.0016
315 MATERNAL EXPOSURE TIMING UNSPECIFIED 6 0.0016
316 RHINITIS ALLERGIC 7 0.0016
317 ENTEROCOLITIS 9 0.0016
318 THERAPEUTIC PRODUCT INEFFECTIVE 6 0.0016
319 RHINOVIRUS INFECTION 6 0.0015
320 HAEMORRHAGIC STROKE 12 0.0015
321 WOUND SECRETION 6 0.0015
322 OSTEOPOROSIS 63 0.0015
323 MATERNAL EXPOSURE DURING PREGNANCY 136 0.0015
324 SYNOVIAL CYST 7 0.0015
325 JOINT DISLOCATION 16 0.0015
326 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
327 INFLAMMATION 78 0.0015
328 PRESCRIBED OVERDOSE 29 0.0015
329 CARDIOVASCULAR DISORDER 38 0.0015
330 SKIN PAPILLOMA 6 0.0015
331 BLEPHARITIS 6 0.0015
332 PRODUCT USE IN UNAPPROVED INDICATION 369 0.0015
333 BRONCHIECTASIS 10 0.0015
334 DERMATITIS 31 0.0015
335 DRY MOUTH 120 0.0015
336 SPINAL FUSION SURGERY 6 0.0015
337 HEPATIC CYST 5 0.0015
338 NORMAL NEWBORN 8 0.0015
339 CONDITION AGGRAVATED 445 0.0015
340 SEPSIS 163 0.0015
341 GASTROOESOPHAGEAL REFLUX DISEASE 117 0.0015
342 SCOLIOSIS 9 0.0015
343 HUMERUS FRACTURE 7 0.0015
344 SEDATION 38 0.0014
345 SOCIAL PROBLEM 6 0.0014
346 EOSINOPHIL COUNT INCREASED 12 0.0014
347 LUPUS-LIKE SYNDROME 13 0.0014
348 STAPHYLOCOCCAL SEPSIS 7 0.0014
349 HYPERVOLAEMIA 7 0.0014
350 MUCOUS STOOLS 7 0.0014
351 LOWER LIMB FRACTURE 27 0.0014
352 PURULENT DISCHARGE 6 0.0014
353 SWELLING 131 0.0014
354 NIGHT SWEATS 45 0.0014
355 GENERAL PHYSICAL HEALTH DETERIORATION 161 0.0014
356 PAIN IN EXTREMITY 409 0.0014
357 RENAL CYST 11 0.0014
358 DIABETES MELLITUS 105 0.0014
359 CAESAREAN SECTION 16 0.0014
360 RASH PUSTULAR 10 0.0014
361 WOUND INFECTION 15 0.0014
362 DRUG INTOLERANCE 132 0.0014
363 PULMONARY CONGESTION 18 0.0014
364 WALKING AID USER 9 0.0014
365 RHINITIS 11 0.0014
366 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
367 FEELING HOT 83 0.0014
368 RASH PRURITIC 73 0.0013
369 MOVEMENT DISORDER 43 0.0013
370 SCAB 15 0.0013
371 DERMATITIS ACNEIFORM 8 0.0013
372 EAR DISORDER 6 0.0013
373 SENSORY DISTURBANCE 21 0.0013
374 LIVER DISORDER 58 0.0013
375 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
376 NEPHROGENIC ANAEMIA 6 0.0013
377 PRODUCT DISTRIBUTION ISSUE 12 0.0013
378 ERYTHEMA 265 0.0013
379 OEDEMA PERIPHERAL 157 0.0013
380 GASTRITIS EROSIVE 6 0.0013
381 PLEURAL EFFUSION 78 0.0013
382 PRE-EXISTING CONDITION IMPROVED 8 0.0013
383 PEMPHIGUS 16 0.0013
384 SKIN REACTION 18 0.0013
385 PRESYNCOPE 31 0.0013
386 AFFECTIVE DISORDER 10 0.0013
387 MUSCLE STRAIN 11 0.0013
388 PRURITUS 488 0.0013
389 SKIN ABRASION 6 0.0013
390 HYPERKERATOSIS 7 0.0013
391 INTENTIONAL PRODUCT MISUSE 111 0.0013
392 SPUTUM DISCOLOURED 12 0.0013
393 FUNGAL INFECTION 42 0.0013
394 PRODUCT PRESCRIBING ERROR 30 0.0013
395 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 23 0.0013
396 TRANSIENT ISCHAEMIC ATTACK 42 0.0012
397 EAR INFECTION 33 0.0012
398 CONJUNCTIVITIS 23 0.0012
399 HERPES SIMPLEX 8 0.0012
400 APPLICATION SITE DISCOLOURATION 5 0.0012
401 MYOSITIS 11 0.0012
402 ANGINA PECTORIS 35 0.0012
403 HYPERURICAEMIA 5 0.0012
404 NIGHTMARE 42 0.0012
405 URTICARIA 203 0.0012
406 INCORRECT PRODUCT ADMINISTRATION DURATION 26 0.0012
407 CONGESTIVE CARDIOMYOPATHY 5 0.0012
408 DRY SKIN 160 0.0012
409 HYPERSENSITIVITY 221 0.0012
410 ANAEMIA 227 0.0012
411 POSTOPERATIVE WOUND INFECTION 8 0.0012
412 ORAL HERPES 23 0.0012
413 MUSCULOSKELETAL STIFFNESS 103 0.0012
414 ECCHYMOSIS 8 0.0012
415 DISCOMFORT 71 0.0012
416 HEPATIC LESION 5 0.0012
417 CHAPPED LIPS 5 0.0012
418 EYE INFECTION 13 0.0012
419 DRUG INEFFECTIVE 1516 0.0011
420 PERIPHERAL SWELLING 176 0.0011
421 RIGHT VENTRICULAR FAILURE 8 0.0011
422 IMMUNOSUPPRESSION 10 0.0011
423 PIGMENTATION DISORDER 7 0.0011
424 BLOOD CREATININE INCREASED 74 0.0011
425 GINGIVAL SWELLING 5 0.0011
426 HYPERTENSION 239 0.0011
427 DIVERTICULUM 8 0.0011
428 GALLBLADDER DISORDER 20 0.0011
429 ARTHRITIS 88 0.0011
430 GRAFT VERSUS HOST DISEASE 8 0.0011
431 OSTEOARTHRITIS 47 0.0011
432 ERYTHEMA OF EYELID 6 0.0011
433 ROAD TRAFFIC ACCIDENT 46 0.0011
434 MEDICATION ERROR 61 0.0011
435 HIDRADENITIS 10 0.0011
436 THERAPY PARTIAL RESPONDER 17 0.0011
437 OEDEMA 59 0.0011
438 IRON DEFICIENCY ANAEMIA 10 0.0011
439 SARS-COV-2 TEST POSITIVE 14 0.0011
440 MUSCLE SPASMS 193 0.0011
441 MIGRAINE 100 0.0010
442 POOR QUALITY PRODUCT ADMINISTERED 11 0.0010
443 HERPES VIRUS INFECTION 6 0.0010
444 RESTLESSNESS 38 0.0010
445 FOOD ALLERGY 8 0.0010
446 ENTEROCOCCAL INFECTION 5 0.0010
447 ABDOMINAL DISTENSION 108 0.0010
448 MADAROSIS 12 0.0010
449 FIBROMYALGIA 25 0.0010
450 IMPAIRED GASTRIC EMPTYING 14 0.0010
451 VITAMIN D DEFICIENCY 10 0.0010
452 CONSTIPATION 223 0.0010
453 DECREASED IMMUNE RESPONSIVENESS 10 0.0010
454 ENERGY INCREASED 6 0.0010
455 BURNING SENSATION 71 0.0010
456 MUSCULOSKELETAL PAIN 53 0.0010
457 TRICUSPID VALVE INCOMPETENCE 8 0.0010
458 SYMPTOM RECURRENCE 6 0.0010
459 WRIST FRACTURE 12 0.0010
460 EXPOSURE DURING PREGNANCY 62 0.0010
461 ERYSIPELAS 5 0.0010
462 SENSORY LOSS 8 0.0010
463 TOXIC SKIN ERUPTION 10 0.0010
464 WEIGHT DECREASED 276 0.0010
465 ABDOMINAL PAIN 230 0.0010
466 HEPATIC ENZYME INCREASED 67 0.0010
467 JOINT SWELLING 118 0.0010
468 SKIN BURNING SENSATION 70 0.0010
469 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 176 0.0010
470 THERAPEUTIC RESPONSE DECREASED 59 0.0010
471 DEPRESSED MOOD 51 0.0010
472 FAECES SOFT 7 0.0010
473 BASAL CELL CARCINOMA 15 0.0010
474 SKIN DISCOLOURATION 44 0.0010
475 LIMB INJURY 26 0.0010
476 RASH 416 0.0010
477 SENSITIVE SKIN 7 0.0009
478 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
479 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 52 0.0009
480 MOBILITY DECREASED 68 0.0009
481 ARTHROPOD BITE 7 0.0009
482 FEELING DRUNK 7 0.0009
483 LEUKOCYTOSIS 17 0.0009
484 C-REACTIVE PROTEIN ABNORMAL 6 0.0009
485 COMPRESSION FRACTURE 5 0.0009
486 LYMPHADENOPATHY 33 0.0009
487 MUSCULOSKELETAL DISCOMFORT 16 0.0009
488 BLOOD IRON DECREASED 11 0.0009
489 BEHAVIOUR DISORDER 5 0.0009
490 DYSURIA 34 0.0009
491 TYPE 2 DIABETES MELLITUS 31 0.0009
492 VERTIGO 56 0.0009
493 PRODUCT DOSE OMISSION IN ERROR 26 0.0009
494 BODY TEMPERATURE DECREASED 9 0.0009
495 HIP ARTHROPLASTY 14 0.0009
496 EOSINOPHILIA 16 0.0009
497 DISABILITY 18 0.0009
498 ANXIETY 258 0.0009
499 PYREXIA 313 0.0009
500 CYSTIC FIBROSIS 5 0.0009
501 ABDOMINAL DISCOMFORT 151 0.0009
502 CARDIOMEGALY 11 0.0009
503 PROTEINURIA 17 0.0009
504 LACRIMATION INCREASED 27 0.0009
505 PULMONARY OEDEMA 40 0.0009
506 THERAPEUTIC PRODUCT EFFECT DECREASED 40 0.0009
507 EYE PRURITUS 30 0.0009
508 INTENTIONAL PRODUCT USE ISSUE 78 0.0009
509 GENERALISED OEDEMA 11 0.0009
510 OROPHARYNGEAL DISCOMFORT 8 0.0009
511 DRUG PRESCRIBING ERROR 17 0.0009
512 GASTROINTESTINAL DISORDER 79 0.0009
513 DRY EYE 44 0.0009
514 TREATMENT FAILURE 73 0.0009
515 GENERALISED ERYTHEMA 5 0.0009
516 MATERNAL EXPOSURE BEFORE PREGNANCY 6 0.0009
517 PNEUMONIA 283 0.0009
518 UROSEPSIS 8 0.0009
519 POST PROCEDURAL INFECTION 7 0.0009
520 WEIGHT FLUCTUATION 9 0.0009
521 RASH MACULAR 30 0.0009
522 COGNITIVE DISORDER 40 0.0009
523 SKIN ULCER 22 0.0009
524 SQUAMOUS CELL CARCINOMA 8 0.0008
525 LEUKAEMIA 8 0.0008
526 ASPARTATE AMINOTRANSFERASE INCREASED 45 0.0008
527 THERMAL BURN 6 0.0008
528 ANKLE FRACTURE 13 0.0008
529 APPLICATION SITE PRURITUS 19 0.0008
530 RASH ERYTHEMATOUS 40 0.0008
531 MUSCLE RIGIDITY 10 0.0008
532 INFECTION 121 0.0008
533 IMPAIRED QUALITY OF LIFE 12 0.0008
534 ACUTE RESPIRATORY FAILURE 16 0.0008
535 DRUG-INDUCED LIVER INJURY 26 0.0008
536 OSTEOMYELITIS 15 0.0008
537 BLOOD PRESSURE DECREASED 55 0.0008
538 LOCALISED INFECTION 20 0.0008
539 FLUID RETENTION 42 0.0008
540 PERICARDIAL EFFUSION 19 0.0008
541 MAJOR DEPRESSION 6 0.0008
542 QUALITY OF LIFE DECREASED 11 0.0008
543 VITAMIN D DECREASED 7 0.0008
544 SCAR 14 0.0008
545 INFLAMMATORY BOWEL DISEASE 8 0.0008
546 LIMB DISCOMFORT 25 0.0008
547 CHOLANGITIS 5 0.0008
548 PHARYNGITIS 10 0.0008
549 OCULAR HYPERAEMIA 38 0.0008
550 BRONCHITIS 59 0.0008
551 SPINAL OSTEOARTHRITIS 7 0.0008
552 OFF LABEL USE 697 0.0008
553 HYPOAESTHESIA 119 0.0008
554 MEMORY IMPAIRMENT 109 0.0008
555 TOXIC EPIDERMAL NECROLYSIS 12 0.0008
556 CATARACT 47 0.0008
557 AORTIC ANEURYSM 6 0.0008
558 ILLNESS 81 0.0008
559 FAECES DISCOLOURED 17 0.0008
560 ARTHROPATHY 43 0.0008
561 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
562 HIATUS HERNIA 10 0.0008
563 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18 0.0008
564 APNOEA 6 0.0008
565 PAIN 473 0.0008
566 EYE DISCHARGE 8 0.0008
567 MULTIPLE ALLERGIES 6 0.0008
568 BLOOD ALKALINE PHOSPHATASE INCREASED 19 0.0008
569 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
570 EYE IRRITATION 44 0.0008
571 SKIN IRRITATION 35 0.0008
572 JOINT STIFFNESS 20 0.0008
573 ASPERGILLUS INFECTION 5 0.0008
574 PRODUCT USE ISSUE 143 0.0008
575 INCREASED TENDENCY TO BRUISE 7 0.0008
576 BLOOD ALBUMIN DECREASED 6 0.0008
577 CARDIAC FAILURE ACUTE 5 0.0007
578 CHOLECYSTITIS CHRONIC 5 0.0007
579 PANIC ATTACK 27 0.0007
580 PHARYNGITIS STREPTOCOCCAL 8 0.0007
581 NECK PAIN 41 0.0007
582 TREATMENT NONCOMPLIANCE 40 0.0007
583 HYPERAESTHESIA 6 0.0007
584 ILEUS 9 0.0007
585 NASOPHARYNGITIS 133 0.0007
586 HEMIPLEGIA 6 0.0007
587 EAR PAIN 14 0.0007
588 FORMICATION 5 0.0007
589 MASS 10 0.0007
590 PHARYNGEAL SWELLING 7 0.0007
591 ORAL PAIN 16 0.0007
592 HERPES ZOSTER 41 0.0007
593 SINUSITIS 73 0.0007
594 REBOUND EFFECT 8 0.0007
595 AMNESIA 46 0.0007
596 SEASONAL ALLERGY 10 0.0007
597 SYSTEMIC LUPUS ERYTHEMATOSUS 25 0.0007
598 PRESCRIBED UNDERDOSE 14 0.0007
599 FEAR OF INJECTION 5 0.0007
600 PSEUDOMONAS INFECTION 6 0.0007
601 PARALYSIS 10 0.0007
602 NEOPLASM 8 0.0007
603 BLOOD MAGNESIUM DECREASED 6 0.0007
604 THERAPEUTIC RESPONSE SHORTENED 23 0.0007
605 DERMATITIS BULLOUS 5 0.0007
606 EPILEPSY 21 0.0007
607 HYPERHIDROSIS 88 0.0007
608 ANKYLOSING SPONDYLITIS 9 0.0007
609 IRRITABILITY 41 0.0007
610 PNEUMONIA ASPIRATION 17 0.0007
611 SOMNOLENCE 137 0.0007
612 GLAUCOMA 13 0.0007
613 RASH MACULO-PAPULAR 15 0.0007
614 MALAISE 295 0.0007
615 TENDERNESS 7 0.0007
616 COLON CANCER 10 0.0007
617 NAUSEA 531 0.0007
618 STAPHYLOCOCCAL INFECTION 22 0.0007
619 BLOOD BILIRUBIN INCREASED 18 0.0007
620 MOUTH ULCERATION 14 0.0007
621 OSTEOPENIA 10 0.0007
622 HYPERGLYCAEMIA 24 0.0007
623 SINUS DISORDER 13 0.0007
624 HAEMATOCRIT DECREASED 13 0.0007
625 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
626 HYPERCALCAEMIA 8 0.0006
627 HEADACHE 406 0.0006
628 OSTEONECROSIS OF JAW 16 0.0006
629 DYSGEUSIA 48 0.0006
630 CYST 8 0.0006
631 RENAL DISORDER 30 0.0006
632 HYPOGLYCAEMIA 31 0.0006
633 WEIGHT INCREASED 143 0.0006
634 DYSPNOEA 361 0.0006
635 CARDIAC FAILURE 51 0.0006
636 DEVICE DEFECTIVE 11 0.0006
637 ARTHRALGIA 262 0.0006
638 STEVENS-JOHNSON SYNDROME 14 0.0006
639 NASAL CONGESTION 37 0.0006
640 PREMATURE DELIVERY 10 0.0006
641 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
642 HEART RATE DECREASED 22 0.0006
643 BACK PAIN 145 0.0006
644 ATELECTASIS 6 0.0006
645 PRODUCT DOSE OMISSION ISSUE 182 0.0006
646 ALOPECIA 121 0.0006
647 RESPIRATORY TRACT INFECTION 16 0.0006
648 PLATELET COUNT INCREASED 8 0.0006
649 LIVER INJURY 15 0.0006
650 GASTROENTERITIS VIRAL 11 0.0006
651 BEDRIDDEN 8 0.0006
652 IMMUNE SYSTEM DISORDER 8 0.0006
653 HAIR DISORDER 5 0.0006
654 VOMITING 285 0.0006
655 IMMUNODEFICIENCY 9 0.0006
656 UPPER LIMB FRACTURE 12 0.0006
657 SPLENOMEGALY 7 0.0006
658 SPINAL PAIN 7 0.0006
659 SEXUAL DYSFUNCTION 7 0.0006
660 WITHDRAWAL SYNDROME 25 0.0006
661 ABDOMINAL PAIN LOWER 15 0.0006
662 COVID-19 PNEUMONIA 7 0.0006
663 SINUS CONGESTION 8 0.0006
664 HEPATIC STEATOSIS 11 0.0006
665 TOOTH ABSCESS 6 0.0006
666 NEUTROPHIL COUNT DECREASED 24 0.0006
667 NEUROPATHY PERIPHERAL 56 0.0006
668 DIABETIC KETOACIDOSIS 14 0.0006
669 TREMOR 96 0.0006
670 NOCTURIA 7 0.0006
671 URINARY INCONTINENCE 17 0.0006
672 WHITE BLOOD CELL COUNT INCREASED 22 0.0006
673 PRODUCT ODOUR ABNORMAL 6 0.0006
674 OROPHARYNGEAL PAIN 53 0.0006
675 APPLICATION SITE ERYTHEMA 15 0.0006
676 CARPAL TUNNEL SYNDROME 8 0.0006
677 INJECTION SITE DISCOMFORT 6 0.0006
678 EYE PAIN 32 0.0006
679 CHEST PAIN 105 0.0006
680 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
681 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
682 EYE SWELLING 21 0.0006
683 HAIR COLOUR CHANGES 7 0.0006
684 THIRST 10 0.0006
685 RED BLOOD CELL COUNT DECREASED 16 0.0006
686 INTERSTITIAL LUNG DISEASE 27 0.0006
687 INJURY 39 0.0006
688 GLYCOSYLATED HAEMOGLOBIN INCREASED 14 0.0006
689 MUSCLE ATROPHY 7 0.0006
690 RESTLESS LEGS SYNDROME 10 0.0005
691 SPINAL FRACTURE 11 0.0005
692 ABDOMINAL PAIN UPPER 113 0.0005
693 DIARRHOEA 354 0.0005
694 OSTEONECROSIS 18 0.0005
695 DEPRESSION 124 0.0005
696 ILL-DEFINED DISORDER 33 0.0005
697 EXPIRED PRODUCT ADMINISTERED 18 0.0005
698 RHINORRHOEA 35 0.0005
699 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
700 INJECTION SITE INDURATION 7 0.0005
701 RASH PAPULAR 12 0.0005
702 PREMATURE BABY 16 0.0005
703 FLUSHING 54 0.0005
704 DYSPNOEA EXERTIONAL 20 0.0005
705 FATIGUE 412 0.0005
706 EMOTIONAL DISTRESS 64 0.0005
707 SEPTIC SHOCK 23 0.0005
708 MENTAL DISORDER 23 0.0005
709 FEBRILE NEUTROPENIA 35 0.0005
710 INTENTIONAL DOSE OMISSION 15 0.0005
711 EYE INFLAMMATION 5 0.0005
712 INSURANCE ISSUE 8 0.0005
713 MALIGNANT MELANOMA 7 0.0005
714 INSOMNIA 139 0.0005
715 ASTHENIA 196 0.0005
716 DEVICE RELATED INFECTION 8 0.0005
717 SYNCOPE 52 0.0005
718 TACHYCARDIA 46 0.0005
719 HOT FLUSH 39 0.0005
720 EYE DISORDER 17 0.0005
721 DIZZINESS POSTURAL 5 0.0005
722 TACHYPNOEA 7 0.0005
723 INFLUENZA 57 0.0005
724 BRAIN FOG 8 0.0005
725 COELIAC DISEASE 5 0.0005
726 URINARY RETENTION 17 0.0005
727 LYMPHOCYTE COUNT DECREASED 9 0.0005
728 APPLICATION SITE RASH 7 0.0005
729 VISUAL IMPAIRMENT 63 0.0005
730 HEAD DISCOMFORT 9 0.0005
731 ATAXIA 6 0.0005
732 PRODUCT PRESCRIBING ISSUE 11 0.0005
733 ALANINE AMINOTRANSFERASE INCREASED 31 0.0005
734 PNEUMOTHORAX 8 0.0005
735 BLADDER DISORDER 5 0.0005
736 HYPOKALAEMIA 23 0.0005
737 BONE DISORDER 9 0.0005
738 MUSCLE TIGHTNESS 8 0.0005
739 THERAPEUTIC RESPONSE UNEXPECTED 22 0.0005
740 DELIRIUM 17 0.0005
741 DECREASED APPETITE 113 0.0005
742 GAIT DISTURBANCE 93 0.0005
743 PARAESTHESIA 75 0.0005
744 KNEE ARTHROPLASTY 10 0.0005
745 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
746 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 22 0.0005
747 HEPATITIS 12 0.0005
748 HAEMATURIA 16 0.0005
749 ROTATOR CUFF SYNDROME 6 0.0005
750 HEPATIC FAILURE 14 0.0005
751 KIDNEY INFECTION 9 0.0005
752 COVID-19 80 0.0005
753 COLD SWEAT 8 0.0005
754 COUGH 126 0.0004
755 ACUTE MYELOID LEUKAEMIA 7 0.0004
756 ISCHAEMIC STROKE 8 0.0004
757 DIZZINESS 222 0.0004
758 INJECTION SITE PAIN 136 0.0004
759 RESPIRATORY TRACT CONGESTION 7 0.0004
760 URINARY TRACT INFECTION 75 0.0004
761 RESPIRATORY DISORDER 13 0.0004
762 CHRONIC KIDNEY DISEASE 33 0.0004
763 DIVERTICULITIS 12 0.0004
764 BLOOD POTASSIUM INCREASED 7 0.0004
765 APHONIA 6 0.0004
766 HYPOCALCAEMIA 8 0.0004
767 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
768 PANCREATITIS 22 0.0004
769 FACE OEDEMA 7 0.0004
770 MYELODYSPLASTIC SYNDROME 6 0.0004
771 HYPERTHYROIDISM 6 0.0004
772 MUSCULAR WEAKNESS 47 0.0004
773 HYPOKINESIA 6 0.0004
774 FEELING ABNORMAL 99 0.0004
775 ADVERSE EVENT 38 0.0004
776 GASTROENTERITIS 6 0.0004
777 HEAD INJURY 13 0.0004
778 CEREBRAL INFARCTION 10 0.0004
779 INJECTION SITE REACTION 28 0.0004
780 MYALGIA 69 0.0004
781 BLOOD PRESSURE INCREASED 62 0.0004
782 RENAL IMPAIRMENT 34 0.0004
783 BLOOD PRESSURE ABNORMAL 8 0.0004
784 APPLICATION SITE IRRITATION 5 0.0004
785 ATRIAL FIBRILLATION 39 0.0004
786 FALL 133 0.0004
787 PREGNANCY 8 0.0004
788 HYPERKALAEMIA 14 0.0004
789 INTESTINAL OBSTRUCTION 15 0.0004
790 APHASIA 12 0.0004
791 ECONOMIC PROBLEM 6 0.0004
792 TINNITUS 18 0.0004
793 INJECTION SITE SWELLING 30 0.0004
794 HAEMOGLOBIN DECREASED 40 0.0004
795 MYELOSUPPRESSION 14 0.0004
796 PULMONARY HYPERTENSION 8 0.0004
797 POLLAKIURIA 16 0.0004
798 UNDERDOSE 28 0.0004
799 GASTRITIS 10 0.0004
800 ABSCESS 6 0.0004
801 ACUTE KIDNEY INJURY 57 0.0004
802 DRUG INTERACTION 59 0.0004
803 SKIN CANCER 8 0.0004
804 RHEUMATOID ARTHRITIS 42 0.0004
805 GASTRIC ULCER 7 0.0004
806 PRODUCT QUALITY ISSUE 50 0.0004
807 DEHYDRATION 49 0.0004
808 INCREASED APPETITE 7 0.0004
809 PLATELET COUNT DECREASED 39 0.0004
810 ACUTE HEPATIC FAILURE 5 0.0004
811 RESPIRATORY DISTRESS 10 0.0004
812 HERNIA 7 0.0004
813 VIRAL INFECTION 12 0.0004
814 COAGULOPATHY 6 0.0004
815 TOOTH DISORDER 8 0.0004
816 HYPOMAGNESAEMIA 5 0.0004
817 HAEMORRHOIDS 7 0.0004
818 RESPIRATORY FAILURE 26 0.0004
819 ADVERSE DRUG REACTION 32 0.0004
820 OXYGEN SATURATION DECREASED 20 0.0004
821 PRODUCT COMPLAINT 9 0.0004
822 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
823 HYPOTENSION 71 0.0004
824 HYPOPHAGIA 9 0.0004
825 BRONCHOSPASM 5 0.0004
826 CYTOKINE RELEASE SYNDROME 7 0.0003
827 HYPERSOMNIA 10 0.0003
828 RENAL FAILURE 46 0.0003
829 FEEDING DISORDER 7 0.0003
830 DEAFNESS 9 0.0003
831 LOCAL SWELLING 6 0.0003
832 ANHEDONIA 9 0.0003
833 DYSPHONIA 20 0.0003
834 SURGERY 20 0.0003
835 ACUTE MYOCARDIAL INFARCTION 10 0.0003
836 ANGIOEDEMA 15 0.0003
837 CARDIOMYOPATHY 5 0.0003
838 SWELLING FACE 22 0.0003
839 DYSPHAGIA 32 0.0003
840 CHOLELITHIASIS 11 0.0003
841 BLOOD POTASSIUM DECREASED 10 0.0003
842 HYPOAESTHESIA ORAL 5 0.0003
843 TOOTHACHE 6 0.0003
844 ACCIDENTAL OVERDOSE 12 0.0003
845 INJECTION SITE URTICARIA 8 0.0003
846 PRURITUS GENERALISED 7 0.0003
847 FEELING COLD 9 0.0003
848 DELUSION 5 0.0003
849 VISION BLURRED 44 0.0003
850 PHOTOPHOBIA 6 0.0003
851 HOSPITALISATION 49 0.0003
852 BLOOD SODIUM DECREASED 6 0.0003
853 PAIN IN JAW 9 0.0003
854 SUICIDAL IDEATION 29 0.0003
855 DISEASE RECURRENCE 15 0.0003
856 HEPATOTOXICITY 7 0.0003
857 SLEEP APNOEA SYNDROME 6 0.0003
858 CYSTITIS 10 0.0003
859 MOOD SWINGS 10 0.0003
860 INJECTION SITE BRUISING 25 0.0003
861 CHEST DISCOMFORT 32 0.0003
862 PANCREATITIS ACUTE 7 0.0003
863 CARDIAC DISORDER 29 0.0003
864 DIPLOPIA 8 0.0003
865 THERAPY INTERRUPTED 22 0.0003
866 CHILLS 36 0.0003
867 DRUG LEVEL INCREASED 5 0.0003
868 INCORRECT DOSE ADMINISTERED 68 0.0003
869 FULL BLOOD COUNT DECREASED 6 0.0003
870 LOSS OF CONSCIOUSNESS 38 0.0003
871 DISEASE PROGRESSION 35 0.0003
872 LETHARGY 17 0.0003
873 HEMIPARESIS 5 0.0003
874 PALLOR 8 0.0003
875 DEEP VEIN THROMBOSIS 19 0.0003
876 INJECTION SITE WARMTH 6 0.0003
877 BLOOD PRESSURE FLUCTUATION 7 0.0003
878 THROAT IRRITATION 13 0.0003
879 ABNORMAL DREAMS 8 0.0003
880 HAEMORRHAGE 30 0.0003
881 NEPHROLITHIASIS 13 0.0003
882 PALPITATIONS 33 0.0003
883 METABOLIC ACIDOSIS 9 0.0003
884 CRYING 10 0.0003
885 LIVER FUNCTION TEST ABNORMAL 8 0.0003
886 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
887 DYSSTASIA 8 0.0003
888 MELAENA 6 0.0003
889 HEART RATE INCREASED 27 0.0003
890 ACCIDENTAL EXPOSURE TO PRODUCT 28 0.0003
891 HAEMATOMA 7 0.0003
892 PANCYTOPENIA 15 0.0003
893 THROMBOCYTOPENIA 30 0.0003
894 ACNE 20 0.0003
895 BLOOD URINE PRESENT 5 0.0003
896 FEELING JITTERY 5 0.0003
897 CONFUSIONAL STATE 42 0.0003
898 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
899 PLASMA CELL MYELOMA 10 0.0003
900 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
901 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
902 DISORIENTATION 10 0.0003
903 MENTAL STATUS CHANGES 7 0.0003
904 UNEVALUABLE EVENT 19 0.0003
905 INJECTION SITE HAEMORRHAGE 20 0.0003
906 MENTAL IMPAIRMENT 6 0.0002
907 LACTIC ACIDOSIS 8 0.0002
908 EXTRA DOSE ADMINISTERED 10 0.0002
909 PRODUCT DOSE OMISSION 16 0.0002
910 MALIGNANT NEOPLASM PROGRESSION 25 0.0002
911 INFLUENZA LIKE ILLNESS 20 0.0002
912 DEVICE MALFUNCTION 17 0.0002
913 NEEDLE ISSUE 7 0.0002
914 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
915 INJECTION SITE PRURITUS 16 0.0002
916 ANGER 8 0.0002
917 CARDIAC FAILURE CONGESTIVE 19 0.0002
918 MYOCARDIAL INFARCTION 41 0.0002
919 EATING DISORDER 5 0.0002
920 DEVICE ISSUE 21 0.0002
921 FOETAL EXPOSURE DURING PREGNANCY 19 0.0002
922 ANAPHYLACTIC SHOCK 6 0.0002
923 UNRESPONSIVE TO STIMULI 6 0.0002
924 HYPOACUSIS 10 0.0002
925 RASH GENERALISED 6 0.0002
926 EXPOSURE VIA SKIN CONTACT 6 0.0002
927 MUCOSAL INFLAMMATION 6 0.0002
928 SEIZURE 26 0.0002
929 BLINDNESS 9 0.0002
930 MOOD ALTERED 6 0.0002
931 FLATULENCE 12 0.0002
932 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
933 BALANCE DISORDER 18 0.0002
934 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
935 BONE PAIN 12 0.0002
936 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
937 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
938 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
939 INJECTION SITE ERYTHEMA 25 0.0002
940 CEREBROVASCULAR ACCIDENT 34 0.0002
941 AGEUSIA 5 0.0002
942 ANAPHYLACTIC REACTION 11 0.0002
943 NEUTROPENIA 27 0.0002
944 INJECTION SITE RASH 6 0.0002
945 DRUG ADMINISTRATION ERROR 6 0.0002
946 THERAPY CESSATION 10 0.0002
947 LUNG NEOPLASM MALIGNANT 8 0.0002
948 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
949 PRODUCT STORAGE ERROR 17 0.0002
950 NERVOUS SYSTEM DISORDER 6 0.0002
951 SWOLLEN TONGUE 6 0.0002
952 INJECTION SITE MASS 7 0.0002
953 BRADYCARDIA 10 0.0002
954 NO ADVERSE EVENT 34 0.0002
955 HIP FRACTURE 6 0.0002
956 FEAR 5 0.0002
957 HALLUCINATION 14 0.0002
958 VISUAL ACUITY REDUCED 6 0.0002
959 LEUKOPENIA 9 0.0002
960 ABORTION SPONTANEOUS 7 0.0002
961 NEOPLASM PROGRESSION 6 0.0002
962 DEATH 145 0.0002
963 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
964 CEREBRAL HAEMORRHAGE 6 0.0002
965 DRUG EFFECT DECREASED 9 0.0002
966 BLOOD GLUCOSE DECREASED 8 0.0002
967 DRUG EFFECT INCOMPLETE 6 0.0002
968 NEOPLASM MALIGNANT 11 0.0002
969 EMOTIONAL DISORDER 5 0.0002
970 BONE DENSITY DECREASED 5 0.0002
971 AGITATION 11 0.0001
972 SUICIDE ATTEMPT 9 0.0001
973 DISTURBANCE IN ATTENTION 8 0.0001
974 DYSKINESIA 6 0.0001
975 CARDIAC ARREST 12 0.0001
976 BLOOD GLUCOSE INCREASED 27 0.0001
977 BREAST CANCER 13 0.0001
978 DRUG DOSE OMISSION 23 0.0001
979 SPEECH DISORDER 7 0.0001
980 DYSARTHRIA 5 0.0001
981 MULTIPLE SCLEROSIS 6 0.0001
982 PRODUCT SUBSTITUTION ISSUE 7 0.0001
983 OVERDOSE 26 0.0001
984 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
985 DEPENDENCE 6 0.0001
986 ARRHYTHMIA 5 0.0001
987 PROSTATE CANCER 8 0.0001
988 DRUG WITHDRAWAL SYNDROME 8 0.0001
989 TOXICITY TO VARIOUS AGENTS 15 0.0001
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
991 DRUG DEPENDENCE 13 0.0001
992 DRUG DOSE OMISSION BY DEVICE 6 0.0001
993 DRUG ABUSE 5 0.0001